Treatment · Repurposed drug
Fluvoxamine / SSRI
An antidepressant with anti-inflammatory properties, tested as a way to prevent long COVID. In a randomized trial it did not work for prevention, an honest negative, though whether SSRIs help established long COVID is a separate open question.
Short version: fluvoxamine during acute COVID did not prevent long COVID in a randomized trial. Whether an SSRI helps established long COVID, given the serotonin findings, is untested rather than disproven.
An antidepressant repurposed
Fluvoxamine is an SSRI with anti-inflammatory (sigma-1) properties that drew interest for COVID. Given the serotonin findings in long COVID, SSRIs are a natural thing to test.1
What the trial showed
In the same COVID-OUT randomized trial where metformin worked, fluvoxamine taken during acute infection did not reduce later long COVID. That is an honest negative for prevention, and it sets a high bar.1
negative for prevention
What is still open
The trial tested prevention during acute infection, not treatment of established long COVID, and not based on the serotonin mechanism. Whether an SSRI helps established long COVID, especially the cognitive symptoms, remains untested rather than ruled out.
What we don't know
Honest about the edges of the evidence. These are open questions, not settled answers.
- Whether an SSRI helps established long COVID symptoms.
- Whether the serotonin findings translate to a treatment.
- Which patients, if any, benefit.
References
Every reference is free to read in full.